Skip to main content
. 2016 Mar 7;22(9):2711–2724. doi: 10.3748/wjg.v22.i9.2711

Table 2.

Clinical evidence for dietary calcium-sensing receptor activators as antidiarrheals in animals and humans1

CaSR agonists Antidiarrheal efficacy Ref.
Calcium ↑intestinal resistance, ↓bacterial colonization and translocation to Salmonella infection in rats [81-84]
↓intestinal permeability in rats [108]
↓diarrhea severity in Salmonella enterocolitis in rats [82]
↓diarrhea onset, ↓severity, ↑ recovery in DSS colitis in rodents [73,74]
↓gut permeability and diarrhea in immune-mediated colitis in HLA-B27 transgenic rats [85]
↓induced intestinal inflammation in mice [35,72]
↓stool volume and duration of diarrheas by viruses or parasites in humans (children) [36]
↓stool weight and duration of diarrhea by ETEC in humans (adults) [87]
↓diarrhea frequency in patients with calcitonin-secreting medullary thyroid cancer [88]
Calcium and magnesium ↓intestinal motility and diarrhea symptoms of morphine withdrawal in mice [62]
Polyamines ↓intestinal motility in mice [63,64]
↓gastrointestinal transit and diarrhea of irritable bowel syndrome in mice [65-67]
↓DSS colitis in rodents [73]
Tryptophan ↓intestinal inflammation in mice [109]
↓DSS colitis in rodents [73]

1The naturally occurring calcium-sensing receptor (CaSR) activators described are all friendly minerals or nutrients and generally safe. Except for chemically synthesized polyamines, no adverse events other than mild GI discomforts (e.g., constipation[36,88], flatulence[88] and bloating[88]) were reported. DSS: Dextran sodium sulfate; ETEC: Enterotoxigenic Escherichia coli.